Seagen Inc.
Biological Products, (No Diagnostic Substances) · 21823 30TH DRIVE SE, SUITE, BOTHELL, WA 98021
공식 등기 데이터
0팔로워
1997설립
Seagen Inc. 소개
Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington, was considered the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells, with its development of drugs such as Adcetris, Padcev, and Tivdak. Antibody-drug conjugates are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity.
Source: Wikipedia
산업Biological Products, (No Diagnostic Substances)
본사21823 30TH DRIVE SE, SUITE, BOTHELL, WA 98021
설립1997
법적 형태C Corporation
상태운영 중
특허특허 889건
ANTI-PD-L1 ANTIBODIES AND ANTIBODY-DRUG CONJUGATESUS20260242481A1 · 2026
TREATING LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER WITH ANTI-191P4D12 ANTIBODY DRUG CONJUGATES IN COMBINATION WITH PEMBROLIZUMABEP4780498A1 · 2026
주요 수치
법적 정보
| 법인명 | Seagen Inc. |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 1060736SEC EDGAR에서 보기 ↗ |
| EIN | 91-1874389 |
| 업종 코드(SIC) | 2836 |
| 등기 주소 | 21823 30TH DRIVE SE, SUITE, BOTHELL, WA 98021 |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 10월 15일 업데이트
연락처 및 링크
위치
21823 30TH DRIVE SE, SUITE, BOTHELL, WA 98021
귀하의 회사인가요?
이 페이지를 무료로 신청하여 로고, 제품, 사진, 채용 공고를 추가하고 리뷰에 답변하세요.
이 페이지 신청